Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy NuCana stock | $3.06

Learn how to easily invest in NuCana stock.

NuCana plc
-$0.04 (-1.88%)

NuCana plc is a biotechnology business based in the US. NuCana shares (NCNA) are listed on the NASDAQ and all prices are listed in US Dollars. NuCana employs 27 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in NuCana

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NCNA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

NuCana stock price (NASDAQ: NCNA)

Use our graph to track the performance of NCNA stocks over time.

NuCana shares at a glance

Information last updated 2021-07-30.
Latest market close$3.06
52-week range$2.03 - $7.77
50-day moving average $2.64
200-day moving average $4.23
Wall St. target price$1,144.93
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.63

Buy NuCana shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy NuCana stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NuCana price performance over time

Historical closes compared with the close of $3.06 from 2021-05-28

1 week (2021-07-24) N/A
1 month (2021-07-02) 8.90%
3 months (2021-05-04) -23.31%
6 months (2021-01-31) N/A
1 year (2020-07-31) N/A
2 years (2019-07-31) N/A
3 years (2018-07-31) N/A
5 years (2016-07-31) N/A

NuCana financials

Gross profit TTM $0
Return on assets TTM -26.97%
Return on equity TTM -48.03%
Profit margin 0%
Book value $1.77
Market capitalisation $109.9 million

TTM: trailing 12 months

Shorting NuCana shares

There are currently 798,313 NuCana shares held short by investors – that's known as NuCana's "short interest". This figure is 61% up from 495,942 last month.

There are a few different ways that this level of interest in shorting NuCana shares can be evaluated.

NuCana's "short interest ratio" (SIR)

NuCana's "short interest ratio" (SIR) is the quantity of NuCana shares currently shorted divided by the average quantity of NuCana shares traded daily (recently around 528684.10596026). NuCana's SIR currently stands at 1.51. In other words for every 100,000 NuCana shares traded daily on the market, roughly 1510 shares are currently held short.

However NuCana's short interest can also be evaluated against the total number of NuCana shares, or, against the total number of tradable NuCana shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NuCana's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 NuCana shares in existence, roughly 20 shares are currently held short) or 0.0253% of the tradable shares (for every 100,000 tradable NuCana shares, roughly 25 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NuCana.

Find out more about how you can short NuCana stock.

NuCana share dividends

We're not expecting NuCana to pay a dividend over the next 12 months.

NuCana share price volatility

Over the last 12 months, NuCana's shares have ranged in value from as little as $2.03 up to $7.77. A popular way to gauge a stock's volatility is its "beta".

NCNA.US volatility(beta: 0.77)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NuCana's is 0.766. This would suggest that NuCana's shares are less volatile than average (for this exchange).

NuCana overview

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase III clinical trials for the treatment of patients with biliary tract cancer; Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer; and Phase III clinical trial for the treatment of patients with metastatic pancreatic cancer. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil, which is in Phase I clinical trial for the treatment of patients with advanced solid tumors; and NUC-7738, a nucleoside analog that is in Phase I clinical trial for the treatment of patients with advanced solid tumors and hematological tumors. NuCana plc has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides; and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017.

Frequently asked questions

What percentage of NuCana is owned by insiders or institutions?
Currently 0.409% of NuCana shares are held by insiders and 54.609% by institutions.
How many people work for NuCana?
Latest data suggests 27 work at NuCana.
When does the fiscal year end for NuCana?
NuCana's fiscal year ends in December.
Where is NuCana based?
NuCana's address is: 3 Lochside Way, Edinburgh, United Kingdom, EH12 9DT
What is NuCana's ISIN number?
NuCana's international securities identification number is: US67022C1062
What is NuCana's CUSIP number?
NuCana's Committee on Uniform Securities Identification Procedures number is: 67022C106

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site